Johnson and Johnson

5 Ways One Company Is Working to Boost the Health of the African-American Community

By Susan Segrest
Article

In honor of Black History Month, learn how Johnson & Johnson has made it a mission to help address disparities in healthcare—from partnering with the Black AIDS Institute to reduce HIV infection rates to improving representation in clinical trials.

Campaigns to increase bone marrow registration. Leadership training for nurses. A push for diversity in clinical trials. These are just a few of the ways that Johnson & Johnson is striving to help transform the health of African-Americans and other minorities.

And the need for that transformation is great.

Tech That Protects: 3 Cutting-Edge Innovations That Can Help Make Your Next Surgery Safer

By Kristen Mascia
Summary: 

From a pencil that hoovers up potentially toxic surgical smoke to a 3-D tool that helps reduce exposure to radiation, these Johnson & Johnson Medical Devices Companies advances were designed with one thing in mind: protecting patients and the doctors delivering their care.

Article

From a pencil that hoovers up potentially toxic surgical smoke to a 3-D tool that helps reduce exposure to radiation, these Johnson & Johnson Medical Devices Companies advances were designed with one thing in mind: protecting patients and the doctors delivering their care.

Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis, the World’s #1 Infectious Killer

J&J’s goal is to save an estimated 1.8 million lives and prevent 12 million new TB infections
Press Release

NEW YORK, February 8, 2019 /3BL Media/ - Ahead of the first-ever United Nations (UN) High-Level Meeting on Tuberculosis (TB), Johnson & Johnson announced a comprehensive 10-year initiative in support of the United Nations Sustainable Development Goal target of ending the TB pandemic by 2030.

Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention

Press Release

Johnson & Johnson to collaborate with Apple to assess impact of wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes

Up to 30 percent of AFib cases go undiagnosed until life-threatening complications occur, signaling a critical need for more efficient and scalable screening methods

New Year, New Healthy Habits: 4 Science-Backed Ways to Help Beat Stress in 2019

By Nicole Frehsee Mazur
Article

It can often feel like stress is just an accepted part of life, but that doesn't mean it has to control your life. A few easy behavior tweaks can help set you up for calmer days. This Johnson & Johnson behavior scientist should know.

It’s no secret that January can sometimes be a bit of a downer. The holiday excitement has dwindled. Your finances may be running low, thanks to end-of-year travel and gift-giving. And your only plans on the horizon are sifting through that giant stack of papers on your desk.

12 Simple Tips for Making 2019 Your Healthiest Year Yet

Blog

There's no better time to kick off a wellness regimen than the new year. To help inspire you, we compiled a month-by-month guide of our top expert-backed tips for everything from combating allergies come springtime to getting better shut-eye in 2019.

Anyone who has ever committed to getting healthy knows there's an essential ingredient when it comes to success: having a plan.

Advocating for Our Youngest Innovators #WorldChildrensDay

By Alex Gorsky
Article

Children are born innovators.

They experiment and create marvelous new things. Ask any parent how the constant “why” questions, from their children, have changed how they see the world.

As we look to solve the biggest challenges of the next fifty years—in healthcare and beyond—we will need their most innovative and daring thinking. That all begins with them leading happy and healthy lives, starting with the crucial early years.

This week, in partnership with UNICEF, we harnessed some of these innate talents and celebrated World Children’s Day.

Johnson & Johnson Works with U.S. PEPFAR Program to Expand Access for HIV Treatment-Experienced Children in the Developing World

Together We Intend to Overcome Barriers to Access Treatment and Secure Supply of Pediatric Antiretroviral Therapy Formulations
Press Release

Vatican City,  Johnson & Johnson announced that Janssen Pharmaceutica NV, part of its Janssen Pharmaceutical Companies, is working with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) with the intention of expanding access to lifesaving HIV antiretroviral therapy (ART) for children in the developing world. The initiative seeks to address the fact that only about half of children under age 15 in the developing world are benefiting from ART. This was announced at a conference on pediatric HIV care taking place today in the Vatican City.

Why Your Startup Should Create Impact, Not Advertising

Large organizations like Johnson & Johnson for years have a major stake in the ground as an employer and can offer learnings and best practices for businesses who are looking to incorporate advance planning and real-time response efforts into their DNA
Article

Large organizations like Johnson & Johnson for years have a major stake in the ground as an employer and can offer learnings and best practices for businesses who are looking to incorporate advance planning and real-time response efforts into their DNA. WhenHurricane Maria hit, they didn't just send product, they turned their resources into a full disaster relief organization. 

Pages

Subscribe to Johnson and Johnson